11 January 2019
Change Financial has monetised its investment in the Ivy Project for cash proceeds of US$1.5 million
The monetisation comprises the proceeds of sale of the Company’s 33% equity stake in the Ivy Project and a distribution of capital
- Forums
- ASX - By Stock
- CCA
- Ann: Appendix 4E - Preliminary Final Report
Ann: Appendix 4E - Preliminary Final Report, page-5
Featured News
Add CCA (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.002(2.70%) |
Mkt cap ! $47.70M |
Open | High | Low | Value | Volume |
7.4¢ | 7.8¢ | 7.4¢ | $197.2K | 2.619M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 72000 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.6¢ | 727353 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 72000 | 0.072 |
1 | 500000 | 0.071 |
1 | 642857 | 0.070 |
1 | 50000 | 0.069 |
1 | 75000 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.076 | 727353 | 1 |
0.077 | 14734 | 1 |
0.080 | 147316 | 3 |
0.096 | 150000 | 1 |
0.098 | 37500 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
CCA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online